Qvanteq Company
Qvanteq is a medtech startup company, developing novel bioactive stents to address and overcome the clinical adverse effects of today’s available coronary and endovascular stents. Its bioactive Qstent controls in-growth therefore reducing the risk of restenosis and thrombosis. The company was awarded with the CTI start-up label in 2012.
Qvanteq was founded in 2009 and is held by private investors. The ISO 13485 certified company is based in Zürich, Switzerland. It is a spin-off company from the Swiss Federal Institute of Technology, Zurich.
Employee Number:
1-10
Headquarters:
Zürich, Zurich, Switzerland, Europe
Founded Date:
2009-01-01
Industry:
Implants & Prosthetics
Super Industry:
MedTech & Devices
Phone Number:
41 44 500 98 90
Investors:
Venture Kick, Verve Ventures
Ipo Status:
private
City:
Zürich
Region:
Zurich
Country:
Switzerland
Founders:
Arik Zucker